RESUMO
BACKGROUND: Injections of botulinum toxin type A (BoNT-A) have been proposed as an additional treatment modality for patients suffering chronic temporomandibular disorder (TMD)-related myofascial pain (MFP). BoNT-A impairs muscle function, along with its analgesic effect, and a minimal effective dose should be used. The objective of this randomized placebo-controlled crossover study was to evaluate the clinical benefit of a moderate dose (50 U) of BoNT-A. METHODS: Sixty-six subjects were randomized into two groups, one which received BoNT-A first and a second which received a saline solution (SS) first. Follow-ups were performed 2, 11, and 16 weeks after the injections. Diagnostic criteria for temporomandibular disorders (DC/TMD) diagnostic algorithms were used to evaluate characteristic pain intensity (CPI) and pain-related disability based on the Graded Chronic Pain Scale (GCPS). Electromyographic and bite force were also evaluated. RESULTS: The within-group analysis showed a significant improvement in pain intensity and pain-related disability after BoNT-A (p < 0.001, p = 0.005, p = 0.011) and SS (p = 0.003, p = 0.005, p = 0.046) injections up to week 16. The between-group analysis of pain-related variables revealed no differences between groups at any time. Nonetheless, BoNT-A, but not SS, caused a significant decline in muscle performance. The number needed to treat (NNT) regarding a clinically significant pain reduction (≥30%) was 6.3, 57.0, and 19.0 at 2, 11, and 16-week follow-ups favoring BoNT-A. CONCLUSIONS: Injections of 50 U of BoNT-A might improve MFP symptoms, but the specific effect of the drug on pain compared to the placebo is not obvious.
RESUMO
The hypothesis of the present work was that the pannus tissue overlying the articular hard tissues has an aggressive phenotype and contains the newly discovered collagenase-3 and its endogenous inducers and activators. We therefore analyzed the eventual presence of collagenase-3 and its regulation at the pannus-cartilage junction. Collagenase-3 mRNA (in situ hybridization) and enzyme protein (ABC and immunofluorescence staining) were found in the pannocytes in the pannus-hard tissue junction. Inflammatory round cells associated with the critical interface contained TNF-alpha and IL-1beta. These cytokines induced collagenase-3 secretion in cultured rheumatoid synovial fibroblasts. Procollagenase-3 activators, stromelysin-1, 72 kDa type IV collagenase/gelatinase and membrane-type 1-MMP, were also found in the pannus-hard tissue junction. Active collagenase-3 was inhibited with alendronate (IC50 = 500-750 microM). Collagenase-3, due to its substrate profile and local synthesis in a milieu favoring its activation, might play a major role in the degradation of cartilage type II and bone type I collagens. Alendronate, at concentrations attainable in vivo, is able to inhibit collagenase-3. This might offer an option to control collagenase-3-mediated tissue destruction in rheumatoid arthritis.
Assuntos
Alendronato/farmacologia , Artrite Reumatoide/enzimologia , Cartilagem Articular/enzimologia , Colagenases/metabolismo , Inibidores Enzimáticos/farmacologia , Exsudatos e Transudatos/enzimologia , Metaloproteinases da Matriz/metabolismo , Membrana Sinovial/enzimologia , Adulto , Idoso , Artrite Reumatoide/patologia , Western Blotting , Cartilagem Articular/patologia , Feminino , Humanos , Imuno-Histoquímica , Interleucina-1/metabolismo , Masculino , Metaloproteinase 13 da Matriz , Inibidores de Metaloproteinases de Matriz , Pessoa de Meia-Idade , Membrana Sinovial/patologia , Fator de Necrose Tumoral alfa/metabolismoRESUMO
Tetracyclines (TCs) and their non-antimicrobial analogs (CMTs) have therapeutic potential to inhibit tissue destructive disease processes, such as cancer invasion and metastasis, by inhibiting certain matrix metalloproteinases. Enhanced matrix metalloproteinase-2 (MMP-2; gelatinase A) activity has been correlated to cancer invasiveness, and membrane type MMP (MT1-MMP) expressed by tumor cells is involved in localizing and activating pro-MMP-2, a pathway believed to mediate cancer induced tissue breakdown. CMT-3 (6-demethyl, 6-deoxy, 4-dedimethylamino TC) has been shown to experimentally suppress prostate cancer, colon adenocarcinoma and melanoma invasiveness in cell culture and to inhibit tumor growth and metastasis in vivo and was used in the current in vitro study. Confluent MT1-MMP transfected COS-1 cells were harvested, washed thoroughly, subjected to N(2) cavitation and cell membrane enriched fractions were isolated by sequential centrifugations. This MT1-MMP preparation exhibited (i) pro-MMP-2 activating activity as shown by molecular weight shift of this gelatinase from 72 kDa to 62 kDa using gelatin zymography, and (ii) the ability to degrade both [(3)H-methyl] gelatin and casein at 37 degrees C. Adding CMT-3 at final concentrations of 5--20microM inhibited MT1-MMP gelatinolytic and caseinolytic activity, blocked MT1-MMP activation of pro-MMP-2, and decreased invasiveness (using the Matrigel system) of HT-1080 fibrosarcoma cells. The inhibition of MT1-MMP by CMT-3 may partially explain the inhibition of cancer cell -mediated tissue breakdown and invasiveness by this non-antimicrobial tetracycline analog.
Assuntos
Antineoplásicos/farmacologia , Metaloendopeptidases/metabolismo , Inibidores de Proteases/farmacologia , Tetraciclinas/farmacologia , Animais , Células COS , Chlorocebus aethiops , Ativação Enzimática/efeitos dos fármacos , Precursores Enzimáticos/metabolismo , Fibrossarcoma , Gelatinases/metabolismo , Humanos , Metaloproteinases da Matriz Associadas à Membrana , Metaloendopeptidases/antagonistas & inibidores , Invasividade Neoplásica/prevenção & controle , Proteínas Recombinantes/antagonistas & inibidores , Transfecção , Células Tumorais CultivadasRESUMO
The characterization and regulation of matrix metalloproteinases (MMPs) have been studied to determine their role(s) in periodontal tissue destruction. Progress in elucidating the roles of MMPs in periodontal tissue destruction has led to a new concept involving the chemotherapeutic inhibition on MMPs, a therapeutic strategy which less than a decade ago was considered "a difficult and perhaps impossible task." Tetracyclines/doxycycline (DOXY) and their chemically modified nonantimicrobial derivatives (CMTs) are known to inhibit the matrix metalloproteinases, especially preferring human neutrophil collagenase (MMP-8), and prevent the oxidative activation of procollagenases. We characterized by Western blotting the molecular forms and cellular sources of gingival tissue, dental plaque, gingival crevicular fluid (GCF), and salivary MMPs associated with periodontitis. Also the molecular forms of tissue inhibitors of matrix metalloproteinases (TIMP-1 and TIMP-2) in periodontitis were studied by Western blot. Neutrophil (PMN)-derived MMPs were found to predominate in periodontitis, and phospholipase C present in increased amounts in periodontitis sites was found to be a potential inducer of PMN degranulation. We further studied the effects of DOXY on molecular forms of different latent and active MMPs purified from different cellular sources (PMNs, fibroblasts, keratinocytes) and present in vivo in oral exudates (gingival extracts, GCF, and saliva). DOXY inhibition of activated (oxidatively or proteolytically) MMPs were not associated with MMP fragmentation. Michaelis-Menten plots of initial rates of degradation of soluble type I collagen revealed an apparent Km value of 0.3-0.6 microM for MMP-8, and 75 microM DOXY inhibited MMP-8 in a manner which did not result in changes in apparent Km value but did prevent the initial degradation reaching Vmax providing evidence for noncompetitive inhibition. Treatment of patients with long-term DOXY medication results in decreased MMP-8 activities/levels in gingival tissue, crevicular fluid, and saliva, but not fragmentation of MMP-8 in vivo. These data further support and extend the key role of PMN-MMPs in periodontitis, and the activities of these PMN MMPs can be inhibited directly by therapeutic levels of DOXY.
Assuntos
Doxiciclina/farmacologia , Gengiva/enzimologia , Líquido do Sulco Gengival/enzimologia , Inibidores de Metaloproteinases de Matriz , Doenças Periodontais/enzimologia , Saliva/enzimologia , Western Blotting , Colagenases/metabolismo , Placa Dentária/metabolismo , Gengiva/metabolismo , Líquido do Sulco Gengival/metabolismo , Glicoproteínas/análise , Humanos , Imuno-Histoquímica , Cinética , Metaloproteinase 8 da Matriz , Metaloendopeptidases/antagonistas & inibidores , Neutrófilos/enzimologia , Periodontite/enzimologia , Proteínas/análise , Saliva/metabolismo , Inibidor Tecidual de Metaloproteinase-2 , Inibidores Teciduais de MetaloproteinasesRESUMO
Matrix metalloproteinases (MMPs), especially collagenase-2 (MMP-8), are key mediators of irreversible tissue destruction associated with periodontitis and peri-implantitis. MMP-8 is known to exist in elevated amounts and in active form in the gingival crevicular fluid (GCF) and peri-implant sulcular fluid (PISF) from progressing periodontitis and peri-implantitis lesions and sites, respectively. (Sorsa et al. Ann. N.Y. Acad. Sci. 737: 112-131 [1994]; Teronen et al. J. Dent. Res. 76: 1529-1537 [1997]). We have developed monoclonal antibodies to MMP-8 (Hanemaaijer et al. J. Biol. Chem. 272: 31504-31509 [1997]) that can be used in a chair-side dipstick test to monitor the course and treatment of periodontitis and peri-implantitis. Monoclonal and polyclonal antibody tests for MMP-8 coincided with the classical functional collagenase activity test from GCF and PISF (Sorsa et al. J. Periodont. Res. 22: 386-393 [1988]) in periodontal and peri-implant health and disease. In future a chair-side functional and/or immunological MMP-test can be useful to diagnose and monitor periodontal and peri-implant disease and health.
Assuntos
Colagenases/análise , Implantes Dentários/efeitos adversos , Gengiva/enzimologia , Monitorização Fisiológica/métodos , Doenças Periodontais/diagnóstico , Periodontite/diagnóstico , Periodonto/efeitos dos fármacos , Anticorpos , Anticorpos Monoclonais , Biomarcadores/análise , Colagenases/metabolismo , Humanos , Metaloproteinase 8 da Matriz , Doenças Periodontais/enzimologia , Doenças Periodontais/terapia , Periodontite/enzimologia , Periodontite/etiologia , Periodontite/terapiaRESUMO
Bisphosphonates are a group of drugs capable of inhibiting bone resorption, and are thus used for the treatment of bone diseases, such as Paget's disease, osteoporosis, and for bone metastases of malignant tumors. Their primary cellular target is considered to be the osteoclast. The molecular mechanisms responsible for the downregulation of bone resorption by bisphosphonates have remain unclear. We have discovered that various matrix metalloproteinases (MMPs) are inhibited in vitro by several bisphosphonates. This novel finding may, in part, explain the efficacy of bisphosphonates in their current indications in humans. In enzyme activity tests using purified and recombinant enzymes, we have observed the inhibition of MMP-1, -2, -3, -7, -8, -9, -12, -13, and -14 by clondronate, alendronate, pamidronate, zolendronate, nedrinate, and clodrinate. The IC50s range from 50 to 150 microM. We have also shown that clodronate can downregulate the expression of MT1-MMP protein and mRNA in several cell lines. Additionally, several bisphosphonates decrease the degree of invasion of malignant melanoma (C8161) and fibrosarcoma (HT1080) cells through artificial basement membrane (Matrigel) in cell cultures at IC50s of 50-150 microM and below. Having low toxicity and proven to be well tolerated after several years in human use, bisphosphonates have the potential to become one of the main MMP-inhibitors for MMP-related human soft and hard tissue-destructive diseases in the near future.
Assuntos
Antineoplásicos/farmacologia , Líquidos Corporais/enzimologia , Difosfonatos/farmacologia , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Metaloendopeptidases/genética , Metaloendopeptidases/metabolismo , Inibidores de Proteases/farmacologia , Alendronato/farmacologia , Antineoplásicos/toxicidade , Colagenases/metabolismo , Difosfonatos/toxicidade , Humanos , Metaloendopeptidases/análise , Invasividade Neoplásica/prevenção & controle , Pamidronato , Inibidores de Proteases/toxicidade , Células Tumorais CultivadasRESUMO
Previous studies suggest that salivary and pulp-derived host enzymes, matrix metalloproteinases (MMPs), may be involved in dentin caries pathogenesis. To study the inhibition of acid-activated human salivary MMPs by non-antimicrobial chemically modified tetracyclines (CMTs), we used a functional activity assay with 125I-labeled gelatin as a substrate. To address the role of MMPs in the progression of fissure caries in vivo, we administered the MMP inhibitors CMT-3 and zoledronate to young rats per os for 7 weeks, 5 days a week. Caries lesions were visualized by Schiff reagent in sagittally sectioned mandibular molars. Marked reduction in gelatinolytic activity of human salivary MMPs was observed with CMT-3. CMT-3 and zoledronate, both alone and in combination, also reduced dentin caries progression in the rats. These results suggest that MMPs have an important role in dentin caries pathogenesis, and that MMP inhibitors may prove to be useful in the prevention of caries progression.
Assuntos
Cárie Dentária/enzimologia , Inibidores de Metaloproteinases de Matriz , Proteínas e Peptídeos Salivares/antagonistas & inibidores , Análise de Variância , Animais , Dentina/enzimologia , Difosfonatos/farmacologia , Progressão da Doença , Feminino , Humanos , Imidazóis/farmacologia , Metaloproteinases da Matriz/metabolismo , Inibidores de Proteases/farmacologia , Ratos , Ratos Wistar , Proteínas e Peptídeos Salivares/metabolismo , Estatísticas não Paramétricas , Tetraciclinas/farmacologia , Ácido ZoledrônicoRESUMO
The loosening of dental implants is associated with peri-implant vertical bone loss. The mechanisms and mediators of this bone destruction are not known. To test the hypothesis that collagenase-2 and collagenase-3 might be markers or maybe even mediators in this process, we measured collagenase-2 (time-resolved immunofluorometric assay) and collagenase-3 (quantitative immunoblot) in peri-implant sulcus fluid in 49 implant sites in 13 patients. Vertical bone loss was graded as being < 1 mm, from 1 to 3 mm, or > 3 mm. The severity of inflammation, as rated according to Gingival Index, did not correlate with the category of bone loss (p > 0.05). Collagenase-2 and collagenase-3 were higher (p < 0.05) in the group which had lost > 3 mm of bone than in the two other groups. Gingival Index is not a clinically important marker for bone loss, but collagenase-2 and collagenase-3 in peri-implant sulcus fluid are. They might participate in peri-implant osteolysis.
Assuntos
Perda do Osso Alveolar/enzimologia , Perda do Osso Alveolar/etiologia , Colagenases/metabolismo , Implantes Dentários/efeitos adversos , Adulto , Idoso , Idoso de 80 Anos ou mais , Implantação Dentária Endóssea/efeitos adversos , Falha de Restauração Dentária , Feminino , Líquido do Sulco Gengival/enzimologia , Humanos , Masculino , Metaloproteinase 13 da Matriz , Metaloproteinase 8 da Matriz/metabolismo , Pessoa de Meia-Idade , Índice Periodontal , Estatísticas não ParamétricasRESUMO
The exact molecular mechanisms of the loosening of a dental implant are not well-known. The characteristics of implant sulci are similar to those of periodontal sulci regarding gingival crevicular fluid (GCF) and peri-implant sulcular fluid (PISF). Proteolytic enzymes, matrix metalloproteinases (MMPs), participate in peri-implant tissue remodeling. Clodronate is a well-tolerated bisphosphonate-group drug currently used in bone-resorption-related diseases in humans. The mechanisms of bisphosphonate action are not clarified. Collagenase activity in diseased PISF was significantly higher than in the clinically healthy group. Immunoblotting disclosed that diseased PISF contained increased immunoreactives MMP-8 compared with the healthy PISF. The residual latent collagenase activity in the diseased PISF was activated by gold thioglucose and inhibited completely by 100 microM of doxycycline closely resembling pure neutrophil collagenase (MMP-8). The presence of MMP-8 in diseased but not in clinically healthy PISF may prove to be a useful biochemical indicator to monitor peri-implant health and disease. Pure human neutrophil collagenase (MMP-8) and the MMP-8 present in PISF and in the GCF of both loosening implants and periodontitis-affected teeth were efficiently inhibited in vitro by clodronate (50% inhibition [IC50] was achieved by 150 microM of clodronate), an osteoactive, antiresorptive bisphosphonate. Furthermore, the new finding suggests an extended and hitherto-undescribed potential for clodronate in preventing the loosening of both implants and teeth, based on a dual beneficial effect: prevention of both bone resorption/osteolysis and of soft tissue/dental ligament destruction. Potential new therapeutic indications based on the collagenase-inhibiting effect of clodronate provide potential new therapeutic indications for a variety of diseased involving connective tissue breakdown, such as periodontal disease, arthritides, and tumor invasion.
Assuntos
Cálcio/metabolismo , Ácido Clodrônico/farmacologia , Colagenases/análise , Inibidores Enzimáticos/farmacologia , Líquido do Sulco Gengival/enzimologia , Adulto , Antibacterianos/farmacologia , Artrite/prevenção & controle , Aurotioglucose/farmacologia , Biomarcadores/análise , Remodelação Óssea/efeitos dos fármacos , Reabsorção Óssea/tratamento farmacológico , Reabsorção Óssea/prevenção & controle , Ácido Clodrônico/administração & dosagem , Doenças do Tecido Conjuntivo/prevenção & controle , Implantes Dentários , Falha de Restauração Dentária , Relação Dose-Resposta a Droga , Doxiciclina/farmacologia , Ativação Enzimática , Inibidores Enzimáticos/administração & dosagem , Humanos , Immunoblotting , Metaloproteinase 8 da Matriz , Inibidores de Metaloproteinases de Matriz , Pessoa de Meia-Idade , Osteólise/prevenção & controle , Doenças Periodontais/prevenção & controle , Ligamento Periodontal/efeitos dos fármacos , Periodontite/enzimologia , Mobilidade Dentária/prevenção & controleRESUMO
Metalloproteinases (MMP), particularly MMP-9 produced by the intratumor monocyte/macrophages, play an important role in tumor invasion and metastases. Recent clinical trials in patients with primary breast cancer suggest that bisphosphonates (BP), above all clodronate, may reduce bone metastases. The aim of the present study was to evaluate whether the effects of BPs on cancer dissemination include inhibition of MMP-9 production in human monocyte/macrophages. The effects of clodronate and pamidronate on the MMP-9 expression in and secretion from stimulated human monocyte/macrophages were measured using quantitative reverse transcriptase - polymerase chain reaction (RT-PCR) and enzyme-linked immunoadsorbent assay (ELISA), respectively. The MMP-9 mRNA levels remained relatively stable in the presence of clodronate. In contrast, pamidronate at 30 microM-300 microM increased the mRNA levels 5- to 10-fold. MMP-9 secretion was dose-dependently down-regulated by clodronate whereas pamidronate at 30 microM induced a 50% increase on MMP-9 secretion (p < 0.05), followed by a down-regulation at higher concentrations. The results suggest that MMP-9 is differentially regulated at mRNA and enzyme protein level by BPs, which affect ATP-dependent intracellular enzymes (clodronate) or post-translational modification of GTPases (pamidronate). These findings may have implications for the therapeutic use of these compounds.
Assuntos
Ácido Clodrônico/farmacologia , Difosfonatos/farmacologia , Macrófagos/efeitos dos fármacos , Metaloproteinase 9 da Matriz/biossíntese , Monócitos/efeitos dos fármacos , Meios de Cultivo Condicionados , Relação Dose-Resposta a Droga , Regulação para Baixo , Ativação Enzimática/efeitos dos fármacos , Ensaio de Imunoadsorção Enzimática , Humanos , Técnicas In Vitro , Macrófagos/enzimologia , Monócitos/enzimologia , Pamidronato , RNA Mensageiro/análise , Reação em Cadeia da Polimerase Via Transcriptase ReversaRESUMO
Various matrix growth factors play important roles in the development and growth of cartilage and bone. Among them transforming growth factor-beta superfamily and especially bone morphogenetic proteins are known to be important factors, since they induce bone and cartilage formation in ectopic sites in vivo. We have previously shown that the human osteosarcoma cell line Saos-2 expresses molecules that in vivo induce new bone formation with asymmetric bone maturation. In this study we examined the role of Saos-2-conditioned medium in prolonged cultures of mesenchymal C3H/10T1/2 cells. The C3H/10T1/2 cells were cultured with Saos-2-conditioned medium for 28 days. We show that Saos-2-treated C3H/10T1/2 cells performed retarded osteoblastic differentiation when compared to recombinant BMP-2 and -4 induced differentiation. We further show that this retardation is due to excessive amounts of transforming growth factor-beta in Saos-2-conditioned medium. Our results also suggest that this model can well be used to study additional cofactors involved in retarded osteogenesis.
Assuntos
Osteoblastos/citologia , Osteogênese , Fator de Crescimento Transformador beta/metabolismo , Fator de Crescimento Transformador beta/fisiologia , Fosfatase Alcalina/metabolismo , Animais , Anticorpos/farmacologia , Proteína Morfogenética Óssea 2 , Proteína Morfogenética Óssea 4 , Proteínas Morfogenéticas Ósseas/farmacologia , Diferenciação Celular/efeitos dos fármacos , Linhagem Celular , Tamanho Celular/efeitos dos fármacos , Meios de Cultivo Condicionados , Relação Dose-Resposta a Droga , Humanos , Mesoderma , Camundongos , Microscopia Eletrônica , Osteoblastos/efeitos dos fármacos , Osteoblastos/metabolismo , Osteoblastos/ultraestrutura , Osteocalcina/biossíntese , Osteogênese/efeitos dos fármacos , Proteínas Recombinantes/farmacologia , Fatores de Tempo , Fator de Crescimento Transformador beta/imunologia , Fator de Crescimento Transformador beta/farmacologia , Células Tumorais CultivadasRESUMO
BACKGROUND: Chemically modified non-antimicrobial tetracyclines (CMTs) have been shown to inhibit pathologically elevated collagenase (and other matrix metalloproteinase, MMP) activity and bone resorption in vivo and in vitro. METHODS: In the current study, suboptimal doses of CMT-8 (a non-antimicrobial chemically modified doxycycline) and a bisphosphonate (clodronate, an anti-bone resorption compound) were administered daily, either as a single agent or as a combination therapy, to rats with experimental periodontitis induced by repeated injection of bacterial endotoxin (LPS) into the gingiva. At the end of the 1-week protocol, the gingival tissues were dissected, extracted, and the extracts analyzed for MMPs (collagenases and gelatinases) and for elastase, and the defleshed jaws were morphometrically analyzed for alveolar bone loss. RESULTS: LPS injection significantly (P<0.001) increased alveolar bone loss and increased collagenase (MMP-8), gelatinase (MMP-9), and elastase activities. Treatment of the LPS-injected rats with suboptimal CMT-8 alone or suboptimal clodronate alone produced slight reductions in the tissue-destructive proteinases and no significant reductions in alveolar bone loss. However, a combination of suboptimal CMT-8 and clodronate "normalized" the pathologically elevated levels of MMPs, elastase, and alveolar bone loss, indicating synergistic inhibition of tissue breakdown in this animal model of periodontitis. CONCLUSIONS: Combination of a CMT and a bisphosphonate may be a useful treatment to optimally suppress periodontal destruction and tooth loss and in other tissue-destructive inflammatory diseases such as arthritis.
Assuntos
Perda do Osso Alveolar/prevenção & controle , Ácido Clodrônico/uso terapêutico , Inibidores de Metaloproteinases de Matriz , Inibidores de Proteases/uso terapêutico , Tetraciclinas/uso terapêutico , Perda do Osso Alveolar/enzimologia , Perda do Osso Alveolar/microbiologia , Análise de Variância , Animais , Sinergismo Farmacológico , Quimioterapia Combinada , Gelatinases/antagonistas & inibidores , Lipopolissacarídeos/efeitos adversos , Lipopolissacarídeos/farmacologia , Masculino , Elastase Pancreática/antagonistas & inibidores , Periodontite/induzido quimicamente , Periodontite/microbiologia , Ratos , Ratos Sprague-Dawley , Perda de Dente/prevenção & controleRESUMO
BACKGROUND: Tetracyclines, particularly doxycycline (Doxy), and their non-antimicrobial chemically-modified derivatives (CMTs) inhibit the activities of human matrix metalloproteinases (MMPs), and reduce the severity and progression of periodontal disease in animal models and humans. In this study, the effects of Doxy and CMT-1, -3, and -5 on proteolytic, serpinolytic, and progelatinase-B activation activities of potent periodontopathogens were studied. METHODS: The effect of Doxy and CMTs (0.5 to 50 microM) on proteolytic activities were investigated by incubating bacteria with chromogenic substrates or human serum albumin. A collagenolytic fraction of Porphyromonas gingivalis was used to evaluate the effect of these substances on collagenolytic (type I collagen) and serpinolytic (alpha1-proteinase inhibitor) activities. Lastly, the effect of Doxy on progelatinase-B (pro-MMP-9) activation by purified proteinases from P. gingivalis and Treponema denticola was investigated by SDS-PAGE/Western immunoblotting. RESULTS: Doxy and CMTs, except CMT-5 which lacks the structural elements required for cation chelation, inhibited Arg- and Lys-gingipain activities as well as collagenolytic activity of P. gingivalis. Doxy and CMTs did not markedly affect the chymotrypsin-like activity of T. denticola but inhibited its trypsin-like activity. In addition, degradation of human serum albumin by cells of P. gingivalis and T. denticola was strongly inhibited by Doxy and CMT-1. Doxy and CMT-1 also inhibited the inactivation of alpha1-proteinase inhibitor (serpinolytic activity) by a collagenolytic fraction of P. gingivalis. Lastly, Doxy prevented the latent to active conversion of human neutrophil progelatinase-B (pro-MMP-9) by Arg-gingipains A/B of P. gingivalis but not by the chymotrypsin-like proteinase of T. denticola. CONCLUSIONS: Data from this study suggest that Doxy and CMTs have the potential to inhibit the periodontopathogenic bacterial proteinases, which contribute to tissue destruction cascades during periodontitis directly and indirectly by triggering the host response.
Assuntos
Antibacterianos/farmacologia , Doxiciclina/farmacologia , Inibidores Enzimáticos/farmacologia , Precursores Enzimáticos/antagonistas & inibidores , Gelatinases/antagonistas & inibidores , Metaloendopeptidases/antagonistas & inibidores , Inibidores de Proteases/farmacologia , Inibidores de Serina Proteinase/farmacologia , Serpinas/farmacologia , Adesinas Bacterianas/metabolismo , Western Blotting , Compostos Cromogênicos , Quimotripsina/antagonistas & inibidores , Cisteína Endopeptidases/metabolismo , Inibidores de Cisteína Proteinase/farmacologia , Eletroforese em Gel de Poliacrilamida , Cisteína Endopeptidases Gingipaínas , Hemaglutininas/metabolismo , Humanos , Inibidores de Metaloproteinases de Matriz , Neutrófilos/enzimologia , Porphyromonas gingivalis/enzimologia , Albumina Sérica , Tetraciclina/farmacologia , Tetraciclinas/farmacologia , Treponema/enzimologia , Inibidores da Tripsina/farmacologia , alfa 1-Antitripsina/farmacologiaRESUMO
OBJECTIVES: The first objective of this study was to verify the presence of and identify the molecular forms of matrix metalloproteinases (MMPs), including collagenases (MMP-1, MMP-8, and MMP-13) and gelatinases (MMP-2 and MMP-9), in the synovial fluid (SF) of mild and severe temporomandibular joint internal derangement (TMJ-ID). Another objective was to evaluate whether the SF MMPs are potential diagnostic markers that reflect the stage of intra-articular inflammation in the TMJ. STUDY DESIGN: The subjects were 44 patients with mild (n = 16) or severe (n = 28) TMJ-ID; they were classified on the basis of subjective symptoms, clinical and radiographic findings, and surgical observations. The patients were surgically treated, and SF samples were collected immediately before the operation. The collagenase activity of SF samples was analyzed by means of a type I collagen degradation assay. The levels and molecular forms of the SF MMPs as well as the tissue inhibitors of MMPs (TIMP-1 and TIMP-2) were analyzed with Western immunoblotting and gelatin zymography. RESULTS: The SF of both the mild and the severe TMJ-ID patients exhibited free collagenase activity and activity capable of further degrading the (3/4)(alphaA) fragments. Ninety-two-kilodalton proMMP-9 and its 121-kD complex form, as well as 72-kD proMMP-2 were significantly increased in the mild TMJ-ID group (P <.05 in all cases). Both 70- to 80-kD neutrophil type and 45- to 55-kD mesenchymal cell-type MMP-8 (corresponding to the latent and active forms) were observed in mild and severe TMJ-ID SF, but they predominated in mild TMJ-ID. Both MMP-1 and MMP-13 were observed in both groups, and in mild TMJ-ID SF the low-molecular weight forms of MMP-1 indicated activation of the enzyme. CONCLUSIONS: The degradation of type I collagen in the TMJ is evidently due to the collective action of many collagenolytic MMPs present in the SF of patients with mild and severe TMJ-ID. The elevated levels of MMP-2, MMP-9, and MMP-8 in the SF of patients with mild TMJ-ID eventually reflect the active phase of TMJ destruction. These observations may have considerable diagnostic and therapeutic significance in the management of TMJ disorders.
Assuntos
Metaloproteinases da Matriz/análise , Líquido Sinovial/enzimologia , Transtornos da Articulação Temporomandibular/enzimologia , Adolescente , Adulto , Idoso , Artrite/enzimologia , Biomarcadores/análise , Colágeno/metabolismo , Colagenases/análise , Ativação Enzimática , Precursores Enzimáticos/análise , Feminino , Humanos , Modelos Logísticos , Masculino , Metaloproteinase 1 da Matriz/análise , Metaloproteinase 13 da Matriz , Metaloproteinase 2 da Matriz/análise , Metaloproteinase 8 da Matriz/análise , Metaloproteinase 9 da Matriz/análise , Mesoderma/enzimologia , Pessoa de Meia-Idade , Peso Molecular , Neutrófilos/enzimologia , Fragmentos de Peptídeos/metabolismo , Estatísticas não Paramétricas , Transtornos da Articulação Temporomandibular/classificação , Inibidor Tecidual de Metaloproteinase-1/análise , Inibidor Tecidual de Metaloproteinase-2/análiseAssuntos
Colagenases/análise , Gelatinases/análise , Cistos Maxilomandibulares/enzimologia , Metaloendopeptidases/análise , Animais , Aurotioglucose/farmacologia , Western Blotting , Linhagem Celular , Células Cultivadas , Colagenases/metabolismo , Ativação Enzimática , Epitélio/enzimologia , Gelatinases/metabolismo , Humanos , Cistos Maxilomandibulares/patologia , Cistos Maxilomandibulares/cirurgia , Metaloproteinase 2 da Matriz , Metaloproteinase 9 da Matriz , Metaloendopeptidases/metabolismo , Osteoblastos/enzimologia , Compostos de Fenilmercúrio/farmacologia , Ratos , Hipoclorito de Sódio/farmacologiaAssuntos
Perda do Osso Alveolar/prevenção & controle , Ácido Clodrônico/uso terapêutico , Lipopolissacarídeos/toxicidade , Periodontite/fisiopatologia , Inibidores de Proteases/uso terapêutico , Tetraciclinas/uso terapêutico , Animais , Colagenases/metabolismo , Sinergismo Farmacológico , Quimioterapia Combinada , Gelatinases/metabolismo , Gengiva/enzimologia , Masculino , Periodontite/induzido quimicamente , Periodontite/complicações , Ratos , Ratos Sprague-Dawley , Mobilidade Dentária/prevenção & controleRESUMO
Human neutrophil-type (MMP-8) and fibroblast-type (MMP-1) interstitial collagenase, and their inhibition by tetracyclines in saliva from patients with recurrent aphthous ulcers (RAU) or aphthae, were studied by means of sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and enzymological analyses. In the salivary specimens obtained from patients with aphthae, collagenase was found in endogenously active form and was predominantly of MMP-8 type. Topical rinsing treatment with chlortetracycline (Aureomycin) alleviated the discomfort caused by the lesions but did not reduce salivary collagenase amounts; however in vitro, doxycycline inhibited salivary collagenase totally.
Assuntos
Clortetraciclina/uso terapêutico , Inibidores de Metaloproteinases de Matriz , Estomatite Aftosa/tratamento farmacológico , Estomatite Aftosa/enzimologia , Adolescente , Adulto , Criança , Clortetraciclina/administração & dosagem , Colagenases/metabolismo , Doxiciclina/farmacologia , Eletroforese em Gel de Poliacrilamida , Feminino , Fibroblastos/enzimologia , Humanos , Masculino , Metaloproteinase 1 da Matriz , Metaloproteinase 8 da Matriz , Pessoa de Meia-Idade , Antissépticos Bucais/uso terapêutico , Neutrófilos/enzimologia , Recidiva , Saliva/enzimologiaRESUMO
AIM: To study the presence, levels and molecular forms of matrix metalloproteinase (MMP) -8 (collage-nase-2) in pulpal and periapical inflammation, and the changes in MMP-8 levels in root-canal exudates during root-canal treatment. METHODOLOGY: Periapical exudate samples were collected from 11 necrotic teeth with radiographically verified periapical periodontitis during three root-canal treatment visits with interappointment calcium hydroxide (Ca(OH)2) medication. MMP-8 levels and molecular forms were analyzed with immunofluorescent assay (IFMA) and Western immunoblot. Inflamed pulp tissue and periapical granuloma tissue (n = 10 for both) were obtained from other patients and used for MMP-8 immunohistochemical (IHC) staining. RESULTS: The periapical exudate samples demonstrated marked differences in MMP-8 levels between the teeth in the first visit and significant decrease in MMP-8 levels during the root-canal treatment (P = 0.0107). One specimen failed to show a decrease in MMP-8 below 1000 ng mL(-1) a vertical root fracture was later diagnosed and the tooth extracted. IHC staining showed that in addition to PMN-leucocytes, macrophages and plasma cells produced MMP-8 in pulp and periapical granulomas. CONCLUSIONS: The findings demonstrate the presence of MMP-8 in the inflamed pulp and periapical tissue, indicating that MMP-8 has a role in pulpal and periapical inflammation, most likely participating in tissue extracellular matrix degradation. They further indicate that MMP analysis from periapical exudate could be used to indicate and monitor inflammatory activity and the success of treatment in teeth with periapical lesions.